.svg)
Ever since its establishment in 1989, ZIM Laboratories has been inspired to elevate the state of drugs in modern healthcare by making medicines more convenient in order to improve treatment adherence. Our team of experts, after much contemplation, research, and dialogue, started looking for alternatives that could not only diverge from these traditional methods but introduce an entirely new approach to drug delivery that’s innovative and ready for the changing landscape of healthcare. This urge to introduce technological advancement at such grass root level doesn’t just inspire an objective look at innovation but the immediate applications of technology.
After a decade’s worth of research and the combined intellectual acumen of more than 100 researchers, scientists, and other healthcare professionals, ZIM was able to bring some breakthrough technological innovations at the forefront of the modern “drug revolution”.
In 2000, ZIM introduced the Pellets technology as one of its drug manufacturing methods to make drug delivery more convenient. Pellets offer flexibility in terms of release profiles whether it be controlled release, gastro-resistant, or sustained release. Another interesting advantage of pellets is its ability to release at a certain point while passing through the body.
After successfully developing the pellet technology, ZIM moved to another challenge faced by the patients when it comes to taking drugs - the bitter taste of most drugs. Understanding this challenge as a significant contributor to drug non adherence, especially for pediatric patients, our researchers developed taste masking technology that enhances the taste of the drugs to make it more acceptable without affecting the safety and efficacy of the drug.
This constant pursuit of better drugs led to research and development in Cephalosporins. The relatively new antibiotics have been studied worldwide and have the potential to improve the treatment of infectious diseases. However, there are some side effects to this form of drugs and our researchers are committed to finding out the best ways to improve it. The ongoing research points to a very positive direction as far as Cephalosporins are concerned.
ZIM pioneered the technology of orally disintegrating strips in India, developing and testing various formulations. ZIM aims to make as many drugs as possible, compatible with the OTF technology because of the immense convenience it provides to the patients. Moreover, manufacturing, transporting, and storing the drugs in OTF form is much easier than all the traditional forms of tablets.
This breakthrough technology has the potential to transform the way drugs are administered. These strips dissolve in the mouth instantly, activating the drug ingredients for immediate solution. Also, these strips are easy to carry and combined with the taste masking technology, eliminates the non-adherence in patients due to bitter taste.
Thin Oral is a trademarked product from ZIM that aims to revolutionize the technology across the globe, manufacturing them with a range of formulations fit for all kinds of treatments and medications. For more than 6 years, ZIM has been researching and developing this technology to further its advantages to make room for more improvement and growth.
The innovations at ZIM Laboratories are the result of a strong leadership, committed team members, and a large pool of talent and resources. Led by the Managing Director, Dr. Anwar Daud, the research & development team consists of more than 100 professionals of which 5 are PhD holders and 81 are post graduates. The diverse team has people from all walks of life, offering different viewpoints and perspectives on ideas.
The R&D facility at ZIM Laboratories is a full-fledged lab with state-of-the-art equipment. ZIM laboratories believes in investing in the future to make faster growth and pioneer extraordinary solutions.
For ZIM Laboratories, 2019 has been a fruitful year lined with many achievements and recognition.
At the India Human Capital Summit & Awards in Mumbai, ZIM Laboratories won the award for “Maharashtra Best Employer Brand Award 2019” and on the 56th foundation day of Vidarbha Industries Association, ZIM won “Vidarbha Udyog Gaurav - 2019 under Large Scale Industry”.
ZIM Laboratories was also covered by the media. The CEO magazine did a cover story on ZIM, featuring Dr. Anwar Daud. Moreover, ZIM’s ThinOral technology got covered by Dainik Jagran, highlighting its various benefits, current applications, and future prospects.
ZIM also participated in many national and international pharmaceutical events for showcasing its products, from iPhex -2019 to CHPI, China and CPHI, Delhi. ZIM also participated in the 67th International Scientific and Practical Conference held at Tajik State Medical University in Tajikistan where Dr Anwar Daud addressed a group of doctors during one of the sessions.
In addition to all this, ZIM laboratories also conducted many seminars and awareness programs, both internal and external. In May 2019, an industrial training program for pharmacy students was held at the company premises and later in August, safety training for workers was organized & personal protection equipment were distributed to develop a safety culture.
A health awareness program was also conducted for staff members and workers on serious diseases like Diabetes. Specialists addressed the program along with basic checkups for all the members of the company.
In December 2019, ZIM Laboratories invited Dr. Hanumantha Rao Marepalli, CEO and CSO of Sannova Analytical Inc. for addressing managers and top level management teams on the life skills required to be a good leader. Dr. Anwar Daud addressed the conference as well, explaining the importance of hardwork and commitment.
ZIM also tries to give back to society by participating in various activities for social development. In June 2019, ZIM Laboratories helped a nearby village in converting a dried water stream into a small reservoir for preserving rainwater.
ZIM LABs is an innovative drug delivery solution provider focusing on improving patient convenience and adherence to drug intake. We offer a range of technology-based drug delivery solutions and non-infringing proprietary manufacturing processes for production and supply of innovative and differentiated generic pharmaceutical products to our customers globally. ZIM provides its customers with a comprehensive range of value-added solid dosage differentiated generic products in semi-finished and finished categories/formulations. These include granules, pellets (sustained, modified, extended-release), taste-masked powders, suspensions, tablets, capsules and it’s recently developed Oral Thin Films (OTF).
